Severity and 90-day survival of SARS-CoV-2 infection among patients with haematological disorders

Authors

  • Andreas Glenthøj Department of Haematology, Rigshospitalet, Denmark
  • Lasse H. Jakobsen Department of Haematology, Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
  • Mads Emil Bjørn Department of Haematology, Zeeland University Hospital Roskilde, Roskilde, Denmark
  • Christian B. Poulsen Department of Haematology, Zeeland University Hospital Roskilde, Roskilde, Denmark
  • Henrik Sengeløv Department of Haematology, Rigshospitalet, Denmark
  • Marianne T. Severinsen Department of Haematology, Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
  • Kristian Qvist Section of hematology, Department of Internal Medicine, Hospital Union West, Holstebro, Denmark
  • Ulrik M. Overgaard Department of Haematology, Rigshospitalet, Denmark
  • Syed A. Ahmad Department of Haematology, Rigshospitalet, Denmark
  • Annika Rewes Department of Haematology, Odense University Hospital, Odense, Denmark
  • Ingolf Mølle Department of Haematology, Aarhus University Hospital, Aarhus, Denmark
  • Casper N. Strandholdt Department of Haematology, Hospital of South West Jutland, Esbjerg, Denmark
  • Annette R. Kodahl Department of Oncology, Odense University Hospital, Odense, Denmark; OPEN, Odense University Hospital, Odense, Denmark
  • Jesper Ryg Department of Geriatric Medicine, Odense University Hospital, Odense, Denmark; Department of Clinical Research, University of Southern Denmark, Odense, Denmark; Academy of Geriatric Cancer Research (AgeCare), Odense University Hospital, Odense, Denmark
  • Christian Brieghel Department of Internal Medicine, Section for Infectious Diseases, Herlev and Gentofte Hospital, Herlev, Denmark
  • Isik S. Johansen OPEN, Odense University Hospital, Odense, Denmark; Department of Clinical Research, University of Southern Denmark, Odense, Denmark; Department of Infectious Diseases, Odense University Hospital, Odense, Denmark
  • Karina Kannik Department of Haematology, Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark
  • Søren Jensen-Fangel Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark
  • Lothar Wiese Department of Infectious Diseases, Zeeland University Hospital Roskilde, Roskilde, Denmark
  • Ole Kirk Department of Infectious Diseases, Rigshospitalet, Denmark; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark
  • Michael R. Clausen Department of Haematology, Lillebaelt Hospital Vejle, Vejle, Denmark
  • Marie Helleberg Department of Infectious Diseases, Rigshospitalet, Denmark
  • Henrik Frederiksen Department of Haematology, Odense University Hospital, Odense, Denmark; OPEN, Odense University Hospital, Odense, Denmark; Department of Clinical Research, University of Southern Denmark, Odense, Denmark; Academy of Geriatric Cancer Research (AgeCare), Odense University Hospital, Odense, Denmark

DOI:

https://doi.org/10.1080/0284186X.2022.2026464

Abstract

No abstract available

Downloads

Download data is not yet available.

Downloads

Additional Files

Published

2022-04-03

How to Cite

Glenthøj, A., Jakobsen, L. H., Emil Bjørn, M., Poulsen, C. B., Sengeløv, H., Severinsen, M. T., … Frederiksen, H. (2022). Severity and 90-day survival of SARS-CoV-2 infection among patients with haematological disorders. Acta Oncologica, 61(4), 500–504. https://doi.org/10.1080/0284186X.2022.2026464

Issue

Vol. 61 No. 4 (2022): Acta Oncologica

Section

Articles